ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA
Portfolio Pulse from
Rosen Law Firm is urging investors of Intellia Therapeutics, Inc. who purchased securities between July 30, 2024, and January 8, 2025, to secure legal counsel before the April 14, 2025, deadline for a securities class action.
March 14, 2025 | 12:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is involved in a securities class action lawsuit, with a lead plaintiff deadline on April 14, 2025. Investors who purchased shares during the specified period should consider legal counsel.
The involvement in a securities class action lawsuit can negatively impact investor sentiment and potentially affect the stock price of Intellia Therapeutics in the short term. The legal proceedings may lead to financial liabilities or reputational damage.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100